{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:49:20Z","timestamp":1768873760947,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.semnephrol.2015.08.009","type":"journal-article","created":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T17:30:09Z","timestamp":1448040609000},"page":"478-486","source":"Crossref","is-referenced-by-count":14,"title":["Antiphospholipid Syndrome and the Kidney"],"prefix":"10.1016","volume":"35","author":[{"given":"Savino","family":"Sciascia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Baldovino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Solfietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Roccatello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2015.08.009_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib2","first-page":"319","article-title":"SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up","volume":"74","author":"Worrall","year":"1990","journal-title":"QJM"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00005792-197103000-00001","article-title":"The natural history of systemic lupus erythematosus by prospective analysis","volume":"50","author":"Estes","year":"1971","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.ajkd.2013.11.023","article-title":"Lupus nephritis: the evolving role of novel therapeutics","volume":"63","author":"Rovin","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib5","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib6","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.placenta.2005.04.006","article-title":"The placental bed in pregnancies complicated by primary antiphospholipid syndrome","volume":"27","author":"Stone","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/0961203310395051","article-title":"Task Force on Catastrophic Antiphospholipid Syndrome (APS) and non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions","volume":"20","author":"Cervera","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1191\/0961203302lu157xx","article-title":"Antiphospholipid antibodies do not a syndrome make","volume":"11","author":"Stone","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib10","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00002281-200109000-00006","article-title":"Pathogenic mechanisms mediating antiphospholipid syndrome","volume":"13","author":"Meroni","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrneph.2014.38","article-title":"Renal involvement in antiphospholipid syndrome","volume":"10","author":"Sciascia","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"Giannakopoulos","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib14","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/rheumatology\/kes388","article-title":"GAPSS: the Global Anti-Phospholipid Syndrome Score","volume":"52","author":"Sciascia","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib15","first-page":"397","article-title":"Vasculitis in the antiphospholipid syndrome: culprit or consort?","volume":"21","author":"Lie","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib16","first-page":"1181","article-title":"Renal involvement in primary antiphospholipid syndrome","volume":"19","author":"Amigo","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib17","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2215\/CJN.00460110","article-title":"Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients","volume":"5","author":"Sinico","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib18","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.20433","article-title":"Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome","volume":"50","author":"Tektonidou","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1681\/ASN.V13142","article-title":"Antiphospholipid syndrome nephropathy in systemic lupus erythematosus","volume":"13","author":"Daugas","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.semarthrit.2006.01.001","article-title":"Antiphospholipid syndrome and the kidneys","volume":"35","author":"Uthman","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/qjmed\/93.7.457","article-title":"The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial injury","volume":"93","author":"Griffiths","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.53.1.67","article-title":"Deterioration of renal function in a patient with lupus","volume":"53","author":"Rankin","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib23","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/ndt\/gfq356","article-title":"What nephrologists need to know about antiphospholipid syndrome","volume":"25","author":"Alchi","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib24","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1093\/ndt\/gfs279","article-title":"Thrombotic microangiopathy and associated renal disorders","volume":"27","author":"Barbour","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib25","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.autrev.2014.05.001","article-title":"14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends","volume":"13","author":"Bertolaccini","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00124743-200206000-00008","article-title":"Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment","volume":"8","author":"Asherson","year":"2002","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V103507","article-title":"The intrarenal vascular lesions associated with primary antiphospholipid syndrome","volume":"10","author":"Nochy","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/qjmed\/91.6.401","article-title":"Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis","volume":"91","author":"Bhandari","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib29","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/ar2736","article-title":"Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases","volume":"11","author":"Zheng","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/096120339400300106","article-title":"Renal biopsy in systemic lupus erythematosus: significance of glomerular thrombosis. Analysis of 108 cases","volume":"3","author":"Miranda","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archinte.164.1.77","article-title":"High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus","volume":"164","author":"Ruiz-Irastorza","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.ajkd.2003.09.011","article-title":"Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis","volume":"43","author":"Moroni","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2015.08.009_bib33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/annrheumdis-2013-eular.836","article-title":"Secondary antiphospholipid syndrome nephropathy and lupus nephritis: a case-control study [abstract THU0308]","volume":"72","author":"P\u00e9rez Vel\u00e1squez","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/0961203310397967","article-title":"Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus","volume":"20","author":"Kwok","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib35","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib36","first-page":"795","article-title":"Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure","volume":"68","author":"Kincaid-Smith","year":"1988","journal-title":"QJM"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib37","first-page":"52","article-title":"Post partum renal failure in systemic lupus erythematosus associated with circulating lupus anticoagulant and anticardiolipin antibody","volume":"36","author":"Kincaid-Smith","year":"1991","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/0961203310395803","article-title":"Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies","volume":"20","author":"Ruiz-Irastorza","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.autrev.2014.01.053","article-title":"14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends","volume":"13","author":"Erkan","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art.24232","article-title":"Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies","volume":"61","author":"Tektonidou","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib41","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/rheumatology\/keh490","article-title":"Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation","volume":"44","author":"Sangle","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib42","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1191\/0961203303lu461oa","article-title":"Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy","volume":"12","author":"Korkmaz","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ki.2011.44","article-title":"Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate","volume":"80","author":"Brodsky","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1681\/ASN.V4128","article-title":"Reversible renal failure in the primary antiphospholipid syndrome--a report of two cases","volume":"4","author":"Sokunbi","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib45","first-page":"409","article-title":"Prevention of thrombosis relapse in antiphospholipid syndrome patients refractory to conventional therapy using intravenous immunoglobulin","volume":"30","author":"Sciascia","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib46","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/MBC.0000000000000247","article-title":"Rivaroxaban use in patients with antiphospholipid syndrome and previous venous thromboembolism","volume":"26","author":"Sciascia","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib47","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1177\/0961203312458843","article-title":"A new dawn of anticoagulation for patients with antiphospholipid syndrome?","volume":"21","author":"Giles","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib48","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1177\/0961203311400115","article-title":"Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome","volume":"20","author":"Sciascia","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib49","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/art.37759","article-title":"A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome","volume":"65","author":"Erkan","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncprheum1017","article-title":"New approaches for managing antiphospholipid syndrome","volume":"5","author":"Erkan","year":"2009","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.semnephrol.2015.08.009_bib51","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/0961203310389099","article-title":"Eculizumab and renal transplantation in a patient with catastrophic antiphospholipid syndrome: effect of heparin on complement activation","volume":"20","author":"Velik-Salchner","year":"2011","journal-title":"Lupus"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929515001473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929515001473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T14:48:03Z","timestamp":1653576483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929515001473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0270929515001473"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2015.08.009","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}